My Cart [ 0 ]
New Products
New Services
News
Promotions
Home > Search Results
    31 products and services containing "trastuzumab"
    Please click trastuzumab to try advanced search.
  • C052P: Polatuzumab Biosimilar, CD79B Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The research grade polatuzumab biosimilar specifically binds to the CD79B protein.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by polatuzumab.

  • C061P: Ramucirumab Biosimilar, Human VEGFR2 Monoclonal Antibody

    Recombinant Human IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The monoclonal antibody ramucirumab biosimilar specifically binds to the human VEGFR2 (KDR).
    Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by ramucirumab.

  • C005P: Ranibizumab Biosimilar, Human VEGF Monoclonal Antibody Fragment (Fab)

    Recombinant Humanized Monoclonal Antibody Fragment (Fab) generated from the same parent mouse antibody as bevacizumab.
    Specificity/Sensitivity: The research grade Fab protein ranibizumab specifically binds to the human VEGF-A.
    Applications: Functional assay, neutralization.

  • BS046B:
    Gene synthesis of the variable regions of the recombinant IgG antibodies;
    Molecular construction of the recombinant IgG antibodies;
    0.04 Liter transient production of the recombinant IgG antibodies in CHO cells;
    Protein A purification.

  • C010P: Rituximab Biosimilar, CD20 Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The monoclonal antibody rituximab biosimilar specifically binds to the human TNF alpha.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by rituximab.

  • C108P: Rovalpituzumab Biosimilar, DLL3 Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The research grade rovalpituzumab biosimilar specifically binds to the human DLL3 protein.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by rovalpituzumab.

  • C071P: Sacituzumab Biosimilar, Human Trop-2 Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The monoclonal antibody sacituzumab biosimilar specifically binds to the human Trop-2 protein.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by sacituzumab.

  • C034P: Secukinumab Biosimilar, Human IL17A Monoclonal Antibody

    Recombinant fully human IgG1 monoclonal antibody.
    Specificity/Sensitivity: The monoclonal antibody Secukinumab biosimilar specifically binds to the human IL17A.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by Secukinumab.

  • C110P: Tanezumab Biosimilar, NGF Monoclonal Antibody

    Recombinant Humanized IgG2 Monoclonal Antibody.
    Specificity/Sensitivity: The research grade tanezumab biosimilar specifically binds to the NGF protein.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by tanezumab.

  • C009P: Trastuzumab Biosimilar, HER2/ErbB-2/c-neu Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The monoclonal antibody trastuzumab biosimilar specifically binds to the human HER2 / ErbB-2 / c-neu.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by trastuzumab.

See our Privacy Policy